RFID began many years ago for tracking livestock, but back then it was referred to as Tags and had limited data. Destron Fearing has two kinds of tags, one that is attached to the farm animal, and one that is injected into the animal, whether it be a fish, cow, pig, cat or dog. ”Life chip” is one of the names the injectable RFID is known by today. In Canada most SPCA animal shelters chip the animals before the animal is adopted. Some animals had the chip removed due to CANCER caused by the chip. (see article below)
The well known names “Verichip” (2001) and “Digital Angel” (2000) were the next generation of RFID, but as the idea of this technology was discussed in the media, people had growing concerns over privacy and health effects.
In addition, the Cell Phone industry was already under critizism from users getting brain tumours, which may have set back the RFID implant industry in the early 2000′s. Since that time the company has changed names and is now under the brand names Positive ID (PSID) and Veri Teq, mostly focusing on devices to assist various medical fields, however they are likely still considering the implant rfid for future usage at some point.
Even with the radiation risks, some believe it will be implemented via the Obamacare Health plan as shown in videos below.
RFID tags are classed based upon a frequency or some folks call a read range
- Low Freq Range: 50cm. Use: Good for tagging pets/people
- High Freq Range: 3m. Use: Access control for buildings, doors
- Ultra high Freq Range: 9m. Use: Pallets, Boxes for inventory control
- Microwave Range: >10m. Use: Vehicle tracking
transmitters operating at a frequency of 460 MHz
radio frequency is in the 460 MHz band
RFID Journal says : “Verichip is said by media coverage to be operating at 134 kHZ passive tag ”
Spetrum IEEE says : ”The chip consists primarily of a coil of wire that acts as an antenna and a microchip capable of generating a radio signal that encodes 128 bits of information and is readable from, at most, centimeters away. The reading device emits a magnetic field that oscillates at a frequency of 134 kilohertz. The reader and the chip’s antenna basically form a transformer, turning the oscillating magnetic field into current in the implant.”
It is interesting to see the change in frequency from 460 MHZ to 134 kHZ. Spectum IEEE thinks its only going to send data a few centimetres, where below, Digital Angel and Verichip were thinking longer distances – to cellular antennas and satellites.
Digital Angel Website ( 2000 )
Digital Angel Website ( 2000 )
APPLIED DIGITAL SOLUTIONS INTRODUCES VERICHIP™, A MINIATURIZED, IMPLANTABLE IDENTIFICATION DEVICE WITH A VARIETY OF MEDICAL, SECURITY AND EMERGENCY APPLICATIONS
PALM BEACH, FL — December 19, 2001 – - Applied Digital Solutions, Inc. (Nasdaq: ADSX), an advanced digital technology development company, announced today that it has developed a miniaturized, implantable identification chip — called VeriChip™ — that can be used in a variety of medical, security and emergency applications.
How VeriChip Works
VeriChip is an implantable, 12mm by 2.1mm radio frequency device about the size of the point of a typical ballpoint pen. Each VeriChip will contain a unique identification number and other critical data. Utilizing an external scanner, radio frequency energy passes through the skin energizing the dormant VeriChip, which then emits a radio frequency signal transmitting the identification number and other data contained in the VeriChip. The scanner will display the identification number, but the VeriChip data can also be transmitted, via telephone or the Internet, to an FDA compliant, secure data-storage site. It will then be accessible by authorized personnel. Inserting the VeriChip device is a simple procedure performed in an outpatient, office setting. It requires only local anesthesia, a tiny incision and perhaps a small adhesive bandage. Sutures are not necessary.
Medical Device Identification
Hundreds of thousands of medical devices are surgically implanted into patients every year. Examples of these life-saving and life-enhancing devices include pacemakers, artificial joints, orthopedic hardware, heart valves, and medication pumps. After insertion, these devices often require adjustment, repair, replacement, or even recall. VeriChip, inserted subdermally just above the implanted medical device, provides patients, medical providers, and manufacturers with a rapid, secure and non-invasive method for obtaining medically critical information about the device. VeriChip is a ready source of data about the patient’s name and condition as well as the medical device’s original components, required settings and other essential parameters. Future applications may include full medical record archival/retrieval for emergency medical care.
Emergency or Security-related Identification
Personal identity verification technology has gained considerable interest recently. A great deal of focus has been trained on so-called “biometric” technologies – which identify individuals by their unique biological or physical characteristics, such as fingerprints, voiceprints, retina characteristics, and face recognition points. VeriChip, by contrast, relies on imbedded, tamper-proof, microchip technology, which allows for non-invasive access to identification, medical and other critical data. Use of advanced VeriChip technology means that the threat of theft, loss, duplication or counterfeiting of data is substantially diminished or eliminated. Specific application areas include: enhancement of present forms of identification, search and rescue, and various law enforcement and defense uses.
Commenting on the announcement, Richard J. Sullivan, Chairman and CEO of Applied Digital Solutions stated: “With VeriChip, Applied Digital has taken another significant step in developing leading-edge personal security technologies for a rapidly evolving marketplace. VeriChip joins Digital Angel™ and Thermo Life™ in our repertoire of breakthrough technologies. All of these are designed specifically to save lives, enhance personal security and improve quality of life. We’re looking forward to working with the medical community and other potential partners to bring VeriChip to market as quickly as possible.”
THERMO LIFE ( ADSX – Applied Digital Solutions )
Thermo Life in “Bio Thermo” by Destron Fearing, used in Pigs (2011)
Kevin Rudd’s e-Health bill paves the way for PositiveID human implantable RFID microchips
By Greg Nikolettos Sci Tech 4/12/2010
Grid / RFID : One Mainframe To Rule Them All – Full Version (2009)
VeriMed Patient Identification System
Feb. 26, 2007 – please see also hopetotheend.com/medchip.html
“Target market for The VeriMed system consists of people who are more likely to require emergency medical care, persons with cognitive impairment, persons with chronic diseases and related conditions, and persons with implanted medical devices. CHIP believes their system will be of use for emergency personnel and first responders.
Personally, I foresee a myriad of technology issues here. If these systems are sold to healthcare plans, hospitals or individual potential patients, to hold any value whatsoever the unresponsive future patient would have to be at or taken to a facility using the database with that patient’s information. If these were purchased by facilities, they’re already going to have medical information readily available for their patients in their existing databases.
This system would only have value if a patient is brought in ‘cold’ meaning a hospital or facility would have no existing information on this patient. That is the entire purpose of reading the implanted chip. In that case, what really would be the odds that an implanted patient would just happen to end up being taken to a facility or hospital that bought the system and has access to the database linking the patients implanted chip with the patient information????
…. If the person is institutionalized, that institution will already have information readily available for this person in case of an emergency, so an implant would be of little added help. These would work and be of use only in situations in which the responders had no information on an unresponsive patient…and would require a lot of luck in matching up an implanted patient with a facility that purchased access to the database“
FDA approves computer chip for Humans
Devices could help doctors with stored medical information
updated 10/13/2004 6:38:52 PM ET
WASHINGTON — Medical milestone or privacy invasion? A tiny computer chip approved Wednesday for implantation in a patient’s arm can speed vital information about a patient’s medical history to doctors and hospitals. But critics warn that it could open new ways to imperil the confidentiality of medical records.
The Food and Drug Administration said Wednesday that Applied Digital Solutions of Delray Beach, Fla., could market the VeriChip, an implantable computer chip about the size of a grain of rice, for medical purposes.
With the pinch of a syringe, the microchip is inserted under the skin in a procedure that takes less than 20 minutes and leaves no stitches. Silently and invisibly, the dormant chip stores a code that releases patient-specific information when a scanner passes over it.
Think UPC code. The identifier, emblazoned on a food item, brings up its name and price on the cashier’s screen.
Chip’s dual uses raise alarm
The VeriChip itself contains no medical records, just codes that can be scanned, and revealed, in a doctor’s office or hospital. With that code, the health providers can unlock that portion of a secure database that holds that person’s medical information, including allergies and prior treatment. The electronic database, not the chip, would be updated with each medical visit.
The microchips have already been implanted in 1 million pets. But the chip’s possible dual use for tracking people’s movements — as well as speeding delivery of their medical information to emergency rooms — has raised alarm.
“If privacy protections aren’t built in at the outset, there could be harmful consequences for patients,” said Emily Stewart, a policy analyst at the Health Privacy Project.
The resource you are looking for might have been removed, had its name changed, or is temporarily unavailable.
To protect patient privacy, the devices should reveal only vital medical information, like blood type and allergic reactions, needed for health care workers to do their jobs, Stewart said.
An information technology guru at Detroit Medical Center, however, sees the benefits of the devices and will lobby for his center’s inclusion in a VeriChip pilot program.
“One of the big problems in health care has been the medical records situation. So much of it is still on paper,” said David Ellis, the center’s chief futurist and co-founder of the Michigan Electronic Medical Records Initiative.
‘Part of the future of medicine’
As “medically mobile” patients visit specialists for care, their records fragment on computer systems that don’t talk to each other.
“It’s part of the future of medicine to have these kinds of technologies that make life simpler for the patient,” Ellis said. Pushing for the strongest encryption algorithms to ensure hackers can’t nab medical data as information transfers from chip to reader to secure database, will help address privacy concerns, he said.
The U.S. Department of Health and Human Services on Wednesday announced $139 million in grants to help make real President Bush’s push for electronic health records for most Americans within a decade.
William A. Pierce, an HHS spokesman, could not say whether VeriChip and its accompanying secure database of medical records fit within that initiative.
“Exactly what those technologies are is still to be sorted out,” Pierce said. “It all has to respect and comport with the privacy rules.”
Applied Digital gave away scanners to a few hundred animal shelters and veterinary clinics when it first entered the pet market 15 years ago. Now, 50,000 such scanners have been sold.
To kickstart the chip’s use among humans, Applied Digital will provide $650 scanners for free at 200 of the nation’s trauma centers.
Implantation costs $150 to $200
In pets, installing the chip runs about $50. For humans, the chip implantation cost would be $150 to $200, said Angela Fulcher, an Applied Digital spokeswoman.
Fulcher could not say whether the cost of data storage and encrypted transmission of medical information would be passed to providers.
The resource you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Because the VeriChip is invisible, it’s also unclear how health care workers would know which unconscious patients to scan. Company officials say if the chip use becomes routine, scanning triceps for hidden chips would become second nature at hospitals.
Ultimately, the company hopes patients who suffer from such ailments as diabetes and Alzheimer’s or who undergo complex treatments, like chemotherapy, would have chips implanted. If the procedure proves as popular for use in humans as in pets, that could mean up to 1 million chips implanted in people. So far, just 1,000 people across the globe have had the devices implanted, very few of them in the United States.
The company’s chief executive officer, Scott R. Silverman, is one of a half dozen executives who had chips implanted. Silverman said chips implanted for medical uses could also be used for security purposes, like tracking employee movement through nuclear power plants.
Such security uses are rare in the United States.
Meanwhile, the chip has been used for pure whimsy: Club hoppers in Barcelona, Spain, now use the microchip to enter a VIP area and, through links to a different database, speed payment much like a smartcard.
© 2012 The Associated Press
ANIMALS : “Chip Me NOT”
French Bulldog is Catalyst for Investigation of Microchip-Cancer Connection
French Bulldog Léon
(Léon’s photograph has been reproduced with the permission of the owner)
September 8, 2007
Could a microchip implant like the VeriChip cause cancer? A French Bulldog named Léon was the catalyst for new questions about the safety of RFID implants.
One year ago, Léon’s owner contacted me with startling news. She believed that her dog’s cancerous tumor and his untimely death might have been caused by a microchip implant.
This was not just idle talk by a grieving dog owner grasping at straws to figure out why she had been robbed of her constant companion. This was a gutsy lady who refused to allow the vet to simply cremate the evidence.
This lady prefers to be known only by her first name of “Jeanne,” so the Associated Press couldn’t credit her properly as the original source for some of the explosive information in its article “Chip Implants Linked to Animal Tumors,” but I have the leeway in this forum to share the behind-the-scenes story.
Jeanne spent a small fortune trying to cure her ailing French bulldog, Léon, after he was diagnosed with cancer in 2004. When medical interventions failed and Léon passed away, she decided to hunt for the reason the fatal tumor in his body was attached to the glass-encapsulated microchip that had been injected into his neck for identification purposes.
Jeanne located a team of researchers in Italy who agreed to test tissue samples from a biopsy of Léon’s tumor to determine if the microchip was implicated in his aggressive cancer. They documented their findings in a 2006 paper entitled, “Fibrosarcoma with Typical Features of Postinjection Sarcoma at Site of Microchip Implant in a Dog: Histologic and Immunohistochemical Study.” The full text is available online at: http://www.vetpathology.org/cgi/content/full/43/4/545.
Since Léon’s suspicious cancer was not enough evidence to prove microchip implants were a threat, Jeanne decided to search for other proof of a link. She unearthed scholarly animal studies documenting a possible chip-cancer link and posted several of these at the website that she formed as a tribute to Léon:
Jeanne informed us of this research and even faxed us copies of these studies as they were difficult to obtain. Fortunately, mySpychips co-author Dr. Katherine Albrecht had access to the Harvard library and was able to take Jeanne’s work further, analyzing additional studies that seemed to support a cancer-microchip link in animals.
Sometime later, AP Reporter Todd Lewan entered the picture, eager for an exclusive. He used his press credentials to gain further information, tie up the story with a perfect, documented bow, and broadcast it to media outlets around the world. He and Katherine tirelessly pursued the truth that you can now find published in the explosive AP story.
I promised Jeanne that Katherine and I would share the whole story, and that Léon would be remembered for his contribution. Here’s to you, Jeanne and Léon! I’m so sorry it took tragedy for this information to be brought to light. I applaud your tenacity, bravery, and amazing research skills.
- Liz McIntyre
July 22, 2007
Associated Press article spotlights VeriChip controversy
Hello to CASPIAN members and friends:
The VeriChip battle is heating up! The Associated Press published a feature article today on the human implant controversy that is appearing on newsstands across America:
Chips: High tech aids or tracking tools?
By Todd Lewan, AP National Writer
July 22, 2007
The article is highlighted on the Drudge Report and is printed in over 200 newspapers and news outlets around the country, including USA Today, Business Week, Forbes, Fox News, and the Washington Post.
Major papers in Houston, Seattle, Denver, San Jose, Charlotte, Chicago, Kansas City, Miami, and more have picked up the story. It has even reached the UK Guardian newspaper and outlets in Canada and Australia. For a partial list, see:
The article features a full color photo of our anti-chipping protest in West Palm Beach, Florida and a link to our newhttp://www.AntiChips.com website. It also features quotes by me and my Spychips co-author Liz McIntyre, and mentions our book, “Spychips: How major Corporations and Government Plan to Track Your Every Move with RFID.”
I spoke with Todd Lewan, the AP reporter who wrote the story, and told him everything we know about the downsides of the VeriChip Corporation and its dangerous, Big Brother plans to chip the public. (Liz and I have been posting these stories on our Spychips.com website for several years at http://www.spychips.com/press.html) . Mr. Lewan independently verified many of our concerns and discussed them in the article.
Back in May after our West Palm Beach protest, I asked you all to be patient, as the truth about the VeriChip would soon be coming out. Now our efforts to alert the public are beginning to bear fruit.
Sit tight. This is just the start of the backlash.
Katherine Albrecht, Ed.D.
Dr. Katherine Albrecht
Founder and Director, CASPIAN Consumer Privacy
Host of “Uncovering the Truth”
We the People Radio Network, M-F 10AM-12PM EST
Co-author of “SPYCHIPS: How Major Corporations and Government
Plan to Track Your Every Move with RFID”
Human Chipping: http://www.AntiChips.com
RFID Tagging: http://www.spychips.com
Shopper Cards: http://www.nocards.org
Boycott Gillette: http://www.BoycottGillette.com
Boycott Tesco: http://www.BoycottTesco.com
Bio online at: http://www.spychips.com/media/katherine-albrecht.html
Chip Implants Linked to Animal Tumors
By TODD LEWAN
The Associated Press
Saturday, September 8, 2007; 2:04 PM
– When the U.S. Food and Drug Administration approved implanting microchips in humans, the manufacturer said it would save lives, letting doctors scan the tiny transponders to access patients’ medical records almost instantly. The FDA found “reasonable assurance” the device was safe, and a sub-agency even called it one of 2005′s top “innovative technologies.”
But neither the company nor the regulators publicly mentioned this: A series of veterinary and toxicology studies, dating to the mid-1990s, stated that chip implants had “induced” malignant tumors in some lab mice and rats.
“The transponders were the cause of the tumors,” said Keith Johnson, a retired toxicologic pathologist, explaining in a phone interview the findings of a 1996 study he led at the Dow Chemical Co. in Midland, Mich.
Leading cancer specialists reviewed the research for The Associated Press and, while cautioning that animal test results do not necessarily apply to humans, said the findings troubled them. Some said they would not allow family members to receive implants, and all urged further research before the glass-encased transponders are widely implanted in people.
To date, about 2,000 of the so-called radio frequency identification, or RFID, devices have been implanted in humans worldwide, according to VeriChip Corp. The company, which sees a target market of 45 million Americans for its medical monitoring chips, insists the devices are safe, as does its parent company, Applied Digital Solutions, of Delray Beach, Fla.
“We stand by our implantable products which have been approved by the FDA and/or other U.S. regulatory authorities,” Scott Silverman, VeriChip Corp. chairman and chief executive officer, said in a written response to AP questions.
The company was “not aware of any studies that have resulted in malignant tumors in laboratory rats, mice and certainly not dogs or cats,” but he added that millions of domestic pets have been implanted with microchips, without reports of significant problems.
“In fact, for more than 15 years we have used our encapsulated glass transponders with FDA approved anti-migration caps and received no complaints regarding malignant tumors caused by our product.”
The FDA also stands by its approval of the technology.
Did the agency know of the tumor findings before approving the chip implants? The FDA declined repeated AP requests to specify what studies it reviewed.
The FDA is overseen by the Department of Health and Human Services, which, at the time of VeriChip’s approval, was headed by Tommy Thompson. Two weeks after the device’s approval took effect on Jan. 10, 2005, Thompson left his Cabinet post, and within five months was a board member of VeriChip Corp. and Applied Digital Solutions. He was compensated in cash and stock options.
Thompson, until recently a candidate for the 2008 Republican presidential nomination, says he had no personal relationship with the company as the VeriChip was being evaluated, nor did he play any role in FDA’s approval process of the RFID tag.
“I didn’t even know VeriChip before I stepped down from the Department of Health and Human Services,” he said in a telephone interview.
Also making no mention of the findings on animal tumors was a June report by the ethics committee of the American Medical Association, which touted the benefits of implantable RFID devices.
Had committee members reviewed the literature on cancer in chipped animals?
No, said Dr. Steven Stack, an AMA board member with knowledge of the committee’s review.
Was the AMA aware of the studies?
No, he said.
Published in veterinary and toxicology journals between 1996 and 2006, the studies found that lab mice and rats injected with microchips sometimes developed subcutaneous “sarcomas” _ malignant tumors, most of them encasing the implants.
_ A 1998 study in Ridgefield, Conn., of 177 mice reported cancer incidence to be slightly higher than 10 percent _ a result the researchers described as “surprising.”
_ A 2006 study in France detected tumors in 4.1 percent of 1,260 microchipped mice. This was one of six studies in which the scientists did not set out to find microchip-induced cancer but noticed the growths incidentally. They were testing compounds on behalf of chemical and pharmaceutical companies; but they ruled out the compounds as the tumors’ cause. Because researchers only noted the most obvious tumors, the French study said, “These incidences may therefore slightly underestimate the true occurrence” of cancer.
_ In 1997, a study in Germany found cancers in 1 percent of 4,279 chipped mice. The tumors “are clearly due to the implanted microchips,” the authors wrote.
Caveats accompanied the findings. “Blind leaps from the detection of tumors to the prediction of human health risk should be avoided,” one study cautioned. Also, because none of the studies had a control group of animals that did not get chips, the normal rate of tumors cannot be determined and compared to the rate with chips implanted.
Still, after reviewing the research, specialists at some pre-eminent cancer institutions said the findings raised red flags.
“There’s no way in the world, having read this information, that I would have one of those chips implanted in my skin, or in one of my family members,” said Dr. Robert Benezra, head of the Cancer Biology Genetics Program at the Memorial Sloan-Kettering Cancer Center in New York.
Before microchips are implanted on a large scale in humans, he said, testing should be done on larger animals, such as dogs or monkeys. “I mean, these are bad diseases. They are life-threatening. And given the preliminary animal data, it looks to me that there’s definitely cause for concern.”
Dr. George Demetri, director of the Center for Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute in Boston, agreed. Even though the tumor incidences were “reasonably small,” in his view, the research underscored “certainly real risks” in RFID implants.
In humans, sarcomas, which strike connective tissues, can range from the highly curable to “tumors that are incredibly aggressive and can kill people in three to six months,” he said.
At the Jackson Laboratory in Maine, a leader in mouse genetics research and the initiation of cancer, Dr. Oded Foreman, a forensic pathologist, also reviewed the studies at the AP’s request.
At first he was skeptical, suggesting that chemicals administered in some of the studies could have caused the cancers and skewed the results. But he took a different view after seeing that control mice, which received no chemicals, also developed the cancers. “That might be a little hint that something real is happening here,” he said. He, too, recommended further study, using mice, dogs or non-human primates.
Dr. Cheryl London, a veterinarian oncologist at Ohio State University, noted: “It’s much easier to cause cancer in mice than it is in people. So it may be that what you’re seeing in mice represents an exaggerated phenomenon of what may occur in people.”
Tens of thousands of dogs have been chipped, she said, and veterinary pathologists haven’t reported outbreaks of related sarcomas in the area of the neck, where canine implants are often done. (Published reports detailing malignant tumors in two chipped dogs turned up in AP’s four-month examination of research on chips and health. In one dog, the researchers said cancer appeared linked to the presence of the embedded chip; in the other, the cancer’s cause was uncertain.)
Nonetheless, London saw a need for a 20-year study of chipped canines “to see if you have a biological effect.” Dr. Chand Khanna, a veterinary oncologist at the National Cancer Institute, also backed such a study, saying current evidence “does suggest some reason to be concerned about tumor formations.”
Meanwhile, the animal study findings should be disclosed to anyone considering a chip implant, the cancer specialists agreed.
To date, however, that hasn’t happened.
The product that VeriChip Corp. won approval for use in humans is an electronic capsule the size of two grains of rice. Generally, it is implanted with a syringe into an anesthetized portion of the upper arm.
When prompted by an electromagnetic scanner, the chip transmits a unique code. With the code, hospital staff can go on the Internet and access a patient’s medical profile that is maintained in a database by VeriChip Corp. for an annual fee.
VeriChip Corp., whose parent company has been marketing radio tags for animals for more than a decade, sees an initial market of diabetics and people with heart conditions or Alzheimer’s disease, according to a Securities and Exchange Commission filing.
The company is spending millions to assemble a national network of hospitals equipped to scan chipped patients.
But in its SEC filings, product labels and press releases, VeriChip Corp. has not mentioned the existence of research linking embedded transponders to tumors in test animals.
When the FDA approved the device, it noted some Verichip risks: The capsules could migrate around the body, making them difficult to extract; they might interfere with defibrillators, or be incompatible with MRI scans, causing burns. While also warning that the chips could cause “adverse tissue reaction,” FDA made no reference to malignant growths in animal studies.
Did the agency review literature on microchip implants and animal cancer?
Dr. Katherine Albrecht, a privacy advocate and RFID expert, asked shortly after VeriChip’s approval what evidence the agency had reviewed. When FDA declined to provide information, she filed a Freedom of Information Act request. More than a year later, she received a letter stating there were no documents matching her request.
“The public relies on the FDA to evaluate all the data and make sure the devices it approves are safe,” she says, “but if they’re not doing that, who’s covering our backs?”
Late last year, Albrecht unearthed at the Harvard medical library three studies noting cancerous tumors in some chipped mice and rats, plus a reference in another study to a chipped dog with a tumor. She forwarded them to the AP, which subsequently found three additional mice studies with similar findings, plus another report of a chipped dog with a tumor.
Asked if it had taken these studies into account, the FDA said VeriChip documents were being kept confidential to protect trade secrets. After AP filed a FOIA request, the FDA made available for a phone interview Anthony Watson, who was in charge of the VeriChip approval process.
“At the time we reviewed this, I don’t remember seeing anything like that,” he said of animal studies linking microchips to cancer. A literature search “didn’t turn up anything that would be of concern.”
In general, Watson said, companies are expected to provide safety-and-effectiveness data during the approval process, “even if it’s adverse information.”
Watson added: “The few articles from the literature that did discuss adverse tissue reactions similar to those in the articles you provided, describe the responses as foreign body reactions that are typical of other implantable devices. The balance of the data provided in the submission supported approval of the device.”
Another implantable device could be a pacemaker, and indeed, tumors have in some cases attached to foreign bodies inside humans. But Dr. Neil Lipman, director of the Research Animal Resource Center at Memorial Sloan-Kettering, said it’s not the same. The microchip isn’t like a pacemaker that’s vital to keeping someone alive, he added, “so at this stage, the payoff doesn’t justify the risks.”
Silverman, VeriChip Corp.’s chief executive, disagreed. “Each month pet microchips reunite over 8,000 dogs and cats with their owners,” he said. “We believe the VeriMed Patient Identification System will provide similar positive benefits for at-risk patients who are unable to communicate for themselves in an emergency.”
And what of former HHS secretary Thompson?
When asked what role, if any, he played in VeriChip’s approval, Thompson replied: “I had nothing to do with it. And if you look back at my record, you will find that there has never been any improprieties whatsoever.”
FDA’s Watson said: “I have no recollection of him being involved in it at all.” VeriChip Corp. declined comment.
Thompson vigorously campaigned for electronic medical records and healthcare technology both as governor of Wisconsin and at HHS. While in President Bush’s Cabinet, he formed a “medical innovation” task force that worked to partner FDA with companies developing medical information technologies.
At a “Medical Innovation Summit” on Oct. 20, 2004, Lester Crawford, the FDA’s acting commissioner, thanked the secretary for getting the agency “deeply involved in the use of new information technology to help prevent medication error.” One notable example he cited: “the implantable chips and scanners of the VeriChip system our agency approved last week.”
After leaving the Cabinet and joining the company board, Thompson received options on 166,667 shares of VeriChip Corp. stock, and options on an additional 100,000 shares of stock from its parent company, Applied Digital Solutions, according to SEC records. He also received $40,000 in cash in 2005 and again in 2006, the filings show.
The Project on Government Oversight called Thompson’s actions “unacceptable” even though they did not violate what the independent watchdog group calls weak conflict-of-interest laws.
“A decade ago, people would be embarrassed to cash in on their government connections. But now it’s like the Wild West,” said the group’s executive director, Danielle Brian.
Thompson is a partner at Akin Gump Strauss Hauer & Feld LLP, a Washington law firm that was paid $1.2 million for legal services it provided the chip maker in 2005 and 2006, according to SEC filings.
He stepped down as a VeriChip Corp. director in March to seek the GOP presidential nomination, and records show that the company gave his campaign $7,400 before he bowed out of the race in August.
In a TV interview while still on the board, Thompson was explaining the benefits _ and the ease _ of being chipped when an interviewer interrupted:
“I’m sorry, sir. Did you just say you would get one implanted in your arm?”
“Absolutely,” Thompson replied. “Without a doubt.”
“No concerns at all?”
But to date, Thompson has yet to be chipped himself.
On the Web:
Applied Digital Solutions Makes $30 Million Payment to IBM
Credit, LLC, Satisfying All Outstanding Debt Obligations to IBM
PALM BEACH, Fla.–(BUSINESS WIRE)–June 30, 2003–
Payment Improves the Company’s Cash Flow and Liquidity -
Strengthens Net Worth and Shareholder Equity on Balance Sheet
Applied Digital Solutions, Inc. (Nasdaq: ADSX – News) an advanced technology development company, announced today that it has made a $30 million payment to IBM Credit, LLC, the Company’s former senior secured creditor.
Under the Forbearance Agreement with IBM Credit (announced on March 27, 2003), the Company had the right to purchase all of its debt of approximately $95 million (including accrued interest) with a payment of $30 million by June 30, 2003. This $30 million payment, which was finalized today, satisfies in full the Company’s debt obligations to IBM. In 2002, Applied Digital Solutions and Digital Angel Corporation (AMEX: DOC), which is majority owned by the Company, reported consolidated revenues of $99.6 million.
The payment to IBM Credit increases the Company’s cash flow and liquidity. With this payment, the Company has also significantly strengthened shareholder equity on its balance sheet, increased its net worth, and eliminated the negative cash flow for IBM debt payments. The Company also expects to recognize a gain from the settlement of the IBM debt.
Simultaneous with the $30 million payment, the Company completed a $10.5 million, 8.5% convertible debenture transaction with an investor group. The investors can convert the debentures into shares of ADSX’s common stock (subject, in part, to shareholder approval) or shares of common stock the Company already owns in Digital Angel Corporation. The fixed-price conversion feature represents a 5.0% premium based on current ADSX market prices, subject to dilution provisions. Subject to certain conditions, the regular interest (8.5% per annum) and amortization payments for the 29-month debentures (due June 29, 2006) may be made (at the Company’s option) in cash or the shares the Company owns in DOC.
In addition, ADSX has granted warrants to the investors that are exercisable for approximately 5.35 million shares of ADSX’s common stock, or 950,000 of the shares the Company owns in DOC, or a combination of shares from both companies. The exercise prices represent a 15% premium based upon current market prices, subject to dilution provisions. The warrants vest immediately and expire in June 2007.
“This IBM payment represents an important turning point for Applied Digital,” commented Scott R. Silverman, Chairman and CEO. “In the most recent shareholder conference call and in our 2002 annual report, I referred to satisfaction of our debt obligations to IBM Credit as the first pillar of the Company’s foundation for the future. Now that we have strengthened our capital structure, our priorities are to build on this foundation by achieving cash flow positive operating results and revenue growth through sales of our personal safeguard technologies, particularly Digital Angel(TM) and VeriChip(TM).”
“VeriChip Corporation’s VeriMed™ Medical Solution Is Now Integrated Into the Hospital Demonstration Area of the IBM Solutions Experience Lab Located in Austin, Texas,” Business Wire, 08 September 2005
DIGITAL ANGEL UNVEILED
Human-tracking subdermal implant technology makes debut
Published: 11/01/2000 at 1:00 AM
A NASDAQ-traded company has finally unveiled its long-touted and
highly controversial “Digital Angel” — a subdermal microchip implant
designed not merely for keeping tabs on pets, but for widespread,
worldwide use in tracking human beings.
The high-tech device, engineered by
Applied Digital Solutions,
Inc. had its debut Monday before an overflow crowd of more than 300 invited guests at Cipriani 42nd Street in New York City.
The audience included U.S. Secretary of Commerce Norman Mineta, who addressed the crowd, as well as other government officials, potential joint-venture/licensing partners and press representatives.
Richard J. Sullivan, Applied Digital Solutions’ chairman and CEO, waxed eloquent about the market potential of Digital Angel, claiming the company has “uncovered a total marketplace that is conservatively estimated to exceed $70 billion.”
Randy Geissler, chairman and CEO of Digital Angel.net Inc., a wholly owned subsidiary, zeroed in on potential applications.
“Our analysis shows that we are well-positioned to move quickly into certain applications while developing a number of others. Two areas of particular interest are in the health-care arena,” he said, “monitoring heart disease and respiratory disease patients.” The tracking and monitoring of pets, he added, is also “right up our alley.”
The demonstration, which was conducted by Dr. Peter Zhou and Dr. Keith Bolton, showed how Digital Angel “can be used to monitor a person’s key body functions — such as temperature and pulse — and transmit that data wirelessly, on a real time basis, along with the accurate location of the person, to a web-enabled ground station or monitoring facility,” according to a press statement.
The technology consists of a miniature sensor device, designed to be implanted just under the skin, that captures and wirelessly transmits the “wearer’s” vital body-function data, such as body temperature or pulse, to an Internet-integrated ground station. In addition, the antenna receives information regarding the location of the individual from the GPS satellite. Both sets of data — medical information and location — are then wirelessly transmitted to the ground station and made available on Web-enabled desktop, laptop or wireless devices.
A more sophisticated version of microchip technologies currently used as electronic ID tags for pets, Digital Angel is powered electromechanically through muscle movement, or it can be activated by an outside monitoring facility.
As WorldNetDaily has reported, in addition to locating missing persons and monitoring physiological data, Digital Angel will be marketed as a means of verifying online consumer identity for the burgeoning e-commerce world.
In August, Sullivan told WND, “We are currently talking to a watch maker who is interested in placing the device on the back of their watches.” He added that “technology is being developed that would allow Digital Angel to function from the back of a cellular phone, transmitting bio-sensor information when carried by the user.”
And in an interview last March, the chief scientist, Zhou, told WorldNetDaily he believes the implant will be as popular as cell phones and vaccines.
Digital Angel “will be a connection from yourself to the electronic world. It will be your guardian, protector. It will bring good things to you,” said Zhou.
“We will be a hybrid of electronic intelligence and our own soul,” he added.
If you’d like to sound off on this issue, please take part in the
Read more at http://www.wnd.com/2000/11/4324/#4DVAzu6AKIJ0jBl9.99
RFID – Intelligent transportation system
- Part 1: Reference architecture and definition of parameters to be standardized
- Part 2: Parameters for air interface communications below 135 kHz
- Part 3: Parameters for air interface communications at 13,56 MHz
- Part 4: Parameters for air interface communications at 2,45 GHz
- Part 6: Parameters for air interface communications at 860 MHz to 960 MHz
- Part 7: Parameters for active air interface communications at 433 MHz
As ISO/IEC 18000-6 is a large document that contains multiple types the document is split and has been published in 2012 as:
- Part 6: Parameters for air interface communications at 860 MHz to 960 MHz General
- Part 61: Parameters for air interface communications at 860 MHz to 960 MHz Type A
- Part 62: Parameters for air interface communications at 860 MHz to 960 MHz Type B
- Part 63: Parameters for air interface communications at 860 MHz to 960 MHz Type C
- Part 64: Parameters for air interface communications at 860 MHz to 960 MHz Type D
The various parts of ISO/IEC 18000 describe air interface communication at different frequencies in order to be able to utilize the different physical behaviors. The various parts of ISO/IEC 18000 are developed by ISO/IEC JTC1 SC31, “Automatic Data Capture Techniques”.
Conformance test methods for the various parts of ISO/IEC 18000 are defined in the corresponding parts of ISO/IEC 18047. (See RFID_testing)
Performance test methods are defined in ISO/IEC 18046. (See RFID_testing)
Bob Boyce’s un-requested VeriChip and associated tumor removed
Boyce finally had the second VeriChip implant removed yesterday along with the associated tumor. This time the surgical staff documented the implant with photos, and the surgeon placed the “foreign body” in a specimen container and sealed it to establish chain of custody evidence.
by Sterling D. Allan Pure Energy Systems News Dec 7, 2010 Copyright © 2010
Last year we reported that Bob Boyce, the highly-revered inventor of ultra-efficient electrolysis systems and of a self-charging battery circuit (harnessing energy from the environment, possibly from zero point energy), had contracted terminal cancer and that the originating point was a VeriChip microchip that someone implanted in his right shoulder without his knowledge or permission. He had a chip removed, but it turned out that another chip was still in there, implanted deeper, as confirmed by an X-ray. He’s lived with that one for a year, but finally had it removed yesterday at the Fannin Regional Hospital in Blue Ridge, Georgia.
continue reading this story at :
A second VeriChip microchip implant was removed yesterday from Bob Boyce‘s shoulder, which was placed there without his knowledge or consent. The blue color is from a dye that pinpoints cancerous cells, which are not uncommon to form along with VeriChip implants (ref).
Marketing RFID using Television Shows & Movies
2002 – The Guardian (CBS) – Kids are tracked by a watch with RFID/GPS
2002 – Law and Order SVU – Child tracked by parents incase kidnapped
2004 – CSI Miami – Night club using implants for payment
2000 – Mission Impossible 2 - Secret Agent tracks girlfriend across the globe
…just to name a few.
Marketing RFID in TV Commercials
If this doesn’t wake people up…
Interac implies that something is “Mobile payments are just the beginning, Imagine whats coming NEXT”
If they understood the radiation exposure, they likely would not have tested these on humans. Read the links about Dogs with Cancer.
World first bio-payment with BTC
Home made Bio Payment
UK : Channel 5 EXPOSED: The Gadget Show’s RFID + Human Microchipping propaganda
If this article is true, most media do not seem to be very interested in finding out more about it :
Trump: We Need a Final Solution to the Immigration Problem
NOVEMBER 13, 2015 by R. HOBBUS J.D. - NEW YORK, Ny
…Trump’s plan includes a “revolutionary” method for locating and tracking individuals who have been or are scheduled to be deported from the United States. “Specialists will implant a tiny radio-frequency identification (RFID) chip into the upper right arm of every individual who passes through one of these relocation centers,” Trump said, continuing, “This allows us to track their movements virtually anywhere in the world, in real-time.”…
ADSX (Applied Digital Solutions) is also interested in Smart Meters